169 related articles for article (PubMed ID: 25779849)
1. Suplatast tosilate for treating cutaneous mastocytosis.
Yasudo H; Ando T; Hiwatari M; Oka A
Pediatr Dermatol; 2015; 32(3):e118-9. PubMed ID: 25779849
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of suplatast tosilate, a Th2 cytokine inhibitor based on the Th1/Th2 ratio for allergic disease in children: a retrospective study.
Yoshihara S; Fukuda H; Arisaka O
Arzneimittelforschung; 2011; 61(7):421-4. PubMed ID: 21899211
[TBL] [Abstract][Full Text] [Related]
3. Kimura's disease treated with suplatast tosilate and loratadine.
Ueda T; Arai S; Amoh Y; Katsuoka K
Eur J Dermatol; 2011; 21(6):1020-1. PubMed ID: 21914581
[No Abstract] [Full Text] [Related]
4. [Cough-variant asthma successfully treated with suplatast tosilate].
Fujimori K; Suzuki E; Arakawa M
Arerugi; 1998 Jul; 47(7):694-7. PubMed ID: 9780445
[No Abstract] [Full Text] [Related]
5. A case of recurrent cutaneous eosinophilic vasculitis: successful adjuvant therapy with suplatast tosilate.
Sakuma-Oyama Y; Nishibu A; Oyama N; Saito M; Nakamura K; Kaneko F
Br J Dermatol; 2003 Oct; 149(4):901-3. PubMed ID: 14616398
[No Abstract] [Full Text] [Related]
6. Suplatast tosilate affects the initial increase in specific IgE and interleukin-4 during immunotherapy for perennial allergic rhinitis.
Washio Y; Ohashi Y; Tanaka A; Kakinoki Y; Sugiura Y; Sakamoto H; Yamada K; Matsuda M; Uekawa M; Okamoto H; Nakai Y
Acta Otolaryngol Suppl; 1998; 538():126-32. PubMed ID: 9879412
[TBL] [Abstract][Full Text] [Related]
7. Omalizumab is more effective than suplatast tosilate in the treatment of Japanese cedar pollen-induced seasonal allergic rhinitis.
Nagakura T; Ogino S; Okubo K; Sato N; Takahashi M; Ishikawa T
Clin Exp Allergy; 2008 Feb; 38(2):329-37. PubMed ID: 18070163
[TBL] [Abstract][Full Text] [Related]
8. [Chronic eosinophilic pneumonia successfully treated with suplatast tosilate].
Hamada H; Sakatani M; Nishioka M; Akira M; Yamamoto S; Ueda E; Okano Y; Nakamura Y; Sone S
Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Jun; 35(6):692-7. PubMed ID: 9294307
[TBL] [Abstract][Full Text] [Related]
9. [A case report of eosinophilic cystitis treated with oral suplatast tosilate].
Kuramoto T; Senzaki H; Inagaki T
Hinyokika Kiyo; 2014 Sep; 60(9):447-50. PubMed ID: 25293800
[TBL] [Abstract][Full Text] [Related]
10. Suplatast/tacrolimus combination therapy for refractory facial erythema in adult patients with atopic dermatitis: a meta-analysis study.
Miyachi Y; Katayama I; Furue M
Allergol Int; 2007 Sep; 56(3):269-75. PubMed ID: 17582208
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of pediatric hypereosinophilic syndrome with suplatast tosilate.
Yamada Y; Yoshihara S; Arisaka O
Ann Allergy Asthma Immunol; 2007 Oct; 99(4):380-1. PubMed ID: 17941289
[No Abstract] [Full Text] [Related]
12. Suplatast tosilate alters DC1/DC2 balance in peripheral blood in bronchial asthma.
Yokomura K; Suda T; Matsuda H; Hashizume H; Asada K; Suzuki K; Chida K
J Asthma; 2005 Sep; 42(7):567-70. PubMed ID: 16169790
[TBL] [Abstract][Full Text] [Related]
13. Treatment of non-episodic angioedema associated with eosinophilia with suplatast tosilate, an anti-allergic selective Th2 cytokine inhibitor.
Hashizume H; Umayahara T
Eur J Dermatol; 2014; 24(2):250-2. PubMed ID: 24723649
[No Abstract] [Full Text] [Related]
14. Suplatast tosilate dimethylsulfonium treatment for steroid-dependent nephrotic syndrome.
Ohtomo Y; Fujinaga S; Hattori M
Pediatr Int; 2005 Apr; 47(2):230-1. PubMed ID: 15771702
[No Abstract] [Full Text] [Related]
15. Pemphigoid nodularis associated with psoriatic erythroderma: successful treatment with suplatast tosilate.
Teraki Y; Fukuda T
Br J Dermatol; 2008 Feb; 158(2):424-6. PubMed ID: 18047503
[No Abstract] [Full Text] [Related]
16. Selective enhancement of production of IgE, IgG4, and Th2-cell cytokine during the rebound phenomenon in atopic dermatitis and prevention by suplatast tosilate.
Kimata H
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):293-5. PubMed ID: 10094221
[TBL] [Abstract][Full Text] [Related]
17. [Inhibitory effect of suplatast tosilate on eosinophil migration].
Kobayashi Y; Nagata M; Yamamoto H; Sakamoto Y
Arerugi; 2000 Jul; 49(7):600-3. PubMed ID: 10944827
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of suplatast tosilate on the differentiation and function of monocyte-derived dendritic cells from patients with asthma.
Tanaka A; Minoguchi K; Samson KT; Oda N; Yokoe T; Tazaki T; Yamamoto Y; Yamamoto M; Ohta S; Adachi M
Clin Exp Allergy; 2007 Jul; 37(7):1083-9. PubMed ID: 17581203
[TBL] [Abstract][Full Text] [Related]
19. Effect of suplatast tosilate on airway hyperresponsiveness and inflammation in asthma patients.
Yoshida M; Aizawa H; Inoue H; Matsumoto K; Koto H; Komori M; Fukuyama S; Okamoto M; Hara N
J Asthma; 2002 Sep; 39(6):545-52. PubMed ID: 12375715
[TBL] [Abstract][Full Text] [Related]
20. Suplatast tosilate alleviates nasal symptoms through the suppression of nuclear factor of activated T-cells-mediated IL-9 gene expression in toluene-2,4-diisocyanate-sensitized rats.
Mizuguchi H; Orimoto N; Kadota T; Kominami T; Das AK; Sawada A; Tamada M; Miyagi K; Adachi T; Matsumoto M; Kosaka T; Kitamura Y; Takeda N; Fukui H
J Pharmacol Sci; 2016 Mar; 130(3):151-8. PubMed ID: 26874672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]